Good clinical practice guide for opioids in pain management: the three Ts - titration (trial), tweaking (tailoring), transition (tapering)

Flaminia Coluzzi; Robert Taylor Jr.; Joseph V. Pergolizzi Jr.; Consalvo Mattia; Robert B. Raffa

doi:10.1016/j.bjane.2014.09.005

Miscellaneous

Good clinical practice guide for opioids in pain management: the three Ts - titration (trial), tweaking (tailoring), transition (tapering)

Orientação para boa prática clínica para opioides no tratamento da dor: os três "Ts" - titulação (teste), ajustes (individualização), transição (redução gradual)

Flaminia Coluzzi; Robert Taylor Jr.; Joseph V. Pergolizzi Jr.; Consalvo Mattia; Robert B. Raffa

http://dx.doi.org/10.1016/j.bjane.2014.09.005 Braz J Anesthesiol, vol.66, n3, p.310-317, 2016

PDF

Downloads: 0

Abstract

ABSTRACT BACKGROUND AND OBJECTIVES: Achieving good clinical practice in the use of opioids as part of a comprehensive pain management regimen can face significant challenges. Despite guidelines from governmental and pain society/organization sources, there are still significant hurdles. A review of some basic tenets of opioid analgesia based on current published knowledge and experiences about this important healthcare imperative is warranted. CONTENT: Consistent with guidelines, the literature supports using the lowest total opioid dose that provides adequate pain control with the fewest adverse effects. Titration (or trial) during opioid initiation is a way of starting low and going slow (and assessing the appropriateness of a specific opioid and formulation). Recognizing that multiple factors contribute to an individual's personal experience of pain, the physical, psychological, social, cultural, spiritual, pharmacogenomic, and behavioral factors of the individual patient should be taken into account (tweaking, or tailoring). Finally, for those patients for whom transition (tapering) from opioid is desired, doing so too rapidly can have negative consequences and minimization of problems during this step can be achieved by proper tapering. CONCLUSION: We conclude that a simultaneously aggressive, yet conservative, approach is advocated in the literature in which opioid therapy is divided into three key steps (the 3 T's): titration (or trial), tweaking (or tailoring), and transition (or tapering). Establishment of the 3 T's along with the application of other appropriate good medical practice and clinical experience/judgment, including non-pharmacologic approaches, can assist healthcare providers in the effort to achieve optimal management of pain.

Keywords

Pain management, Opioid, Titration, Tailoring, Tapering

Resumo

RESUMO JUSTIFICATIVA E OBJETIVOS: Uma boa prática clínica com o uso de opioides como parte de um regime abrangente de tratamento da dor pode enfrentar desafios significativos. Apesar das diretrizes provenientes de sociedades/organizações não governamentais para o manejo da dor, ainda existem obstáculos significativos. A revisão de alguns princípios básicos da analgesia com opioide com base na experiência e no conhecimento das publicações atuais sobre esse cuidado importante da saúde é justificável. CONTEÚDO: De acordo com as diretrizes, a literatura apoia o uso da dose total mais baixa de opioides que forneça o controle adequado da dor com menos efeitos adversos. A titulação (teste), ao iniciar a administração de um opioide, é uma maneira de começar com uma concentração baixa e ir devagar (avaliar a adequação da fórmula específica de um opioide). O ajuste (individualização) é reconhecer que vários fatores contribuem para a experiência pessoal da dor de um indivíduo, tais como fatores físicos, psicológicos, sociais, culturais, espirituais, farmacogenômicos e comportamentais. Finalmente, para aqueles pacientes nos quais a transição (redução gradual) do opioide é desejada, fazer essa transição muito rapidamente pode ter consequências negativas e é possível minimizar os problemas durante essa etapa por meio de uma redução gradual. CONCLUSÃO: Uma abordagem simultânea, agressiva, porém conservadora, é defendida na literatura em que a terapia com opioides é dividida em três etapas principais (os 3 Ts - em inglês: titration, tailoring, tapering): titulação (teste), ajuste (individualização) e transição (redução gradual). Estabelecer os três Ts, juntamente com a aplicação de outra boa prática médica e experiência/julgamento clínico, incluindo abordagens não farmacológicas, pode ajudar os profissionais de saúde no esforço para alcançar o tratamento ideal da dor.

Palavras-chave

Tratamento da dor, Opioide, Titulação, Ajuste, Redução gradual

References

committee on advancing painresearch C, and education. Relieving pain in America:a blueprint for transforming prevention, care, educationand research 2012/05/04 edition.. 2011.

Breivik H, Collett B, Ventafridda V. Survey of chronic pain in Europe prevalence, impact on daily life, and treatment. Eur J Pain. 2006;10:287-333.

Reid KJ, Harker J, Bala MM. Epidemiology of chronic non-cancer pain in Europe narrative review of prevalence, pain treatments and pain impact. Curr Med Res Opin. 2011;27:449-62.

Rustoen T, Wahl AK, Hanestad BR. Prevalence and charac- teristics of chronic pain in the general Norwegian population. Eur J Pain. 2004;8:555-65.

Voices of chronic pain: a national study conducted for American Pain Foundation. 2006.

Stewart WF, Ricci JA, Chee E. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290:2443-54.

Raffa RB, Pergolizzi Jr JV. A modern analgesics pain 'pyramid'. J Clin Pharm Ther. 2014;39:4-6.

Martell BA, O'Connor PG, Kerns RD. Systematic review opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146:116-27.

Deshpande A, Furlan A, Mailis-Gagnon A. Opioids for chronic low-back pain. Cochrane Database Syst Rev. 2007:CD004959.

Trescot AM, Helm S, Hansen H. Opioids in the manage- ment of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Phys. 2008;11:S5-62.

Manchikanti L, Abdi S, Atluri S. American society of interventional pain physicians (ASIPP) guidelines for respon- sible opioid prescribing in chronic non-cancer pain Part 2 - Guidance. Pain Phys. 2012;15:S67S116.

Opioids for persistent pain: good prac- tice. 2010.

Guideline for the use of chronic opioid therapy in chronic noncancer pain. Evid Rev.. 2009.

Kahan M, Mailis-Gagnon A, Wilson L. Canadian guideline for safe and effective use of opioids for chronic noncancer pain clinical summary for family physicians. Part 1: General popula- tion. Can Fam Phys. 2011;57:1257-66.

Affairs D.O.V. Clinical practice guideline: management of opioid therapy for chronic pain. 2010.

Interagency guideline on opi- oid dosing for chronic non-cancer pain: an educational aid to improve care and safety with opioid therapy. 2010.

Ambrosio F, Finco G, Mattia C. SIAARTI recommenda- tions for chronic noncancer pain. Miner Anestesiol. 2006;72:859-80.

Coluzzi F, Pappagallo M. Opioid therapy for chronic noncancer pain practice guidelines for initiation and maintenance of ther- apy. Miner Anestesiol. 2005;71:425-33.

Mercadante S. Opioid titration in cancer pain a critical review. Eur J Pain. 2007;11:823-30.

Ngian GS, Guymer EK, Littlejohn GO. The use of opioids in fibromyalgia. Int J Rheum Dis. 2011;14:6-11.

Noble M, Treadwell JR, Tregear SJ. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010:CD006605.

Chou R. 2009 Clinical Guidelines from the American Pain Soci- ety and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain what are the key messages for clinical practice?. Pol Arch Med Wewn. 2009;119:469-77.

Riemsma R, Forbes C, Harker J. Systematic review of tapentadol in chronic severe pain. Curr Med Res Opin. 2011;27:1907-30.

Wolff RF, Aune D, Truyers C. Systematic review of effi- cacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain. Curr Med Res Opin. 2012;28:833-45.

Quang-Cantagrel ND, Wallace MS, Magnuson SK. Opioid substi- tution to improve the effectiveness of chronic noncancer pain control a chart review. Anesth Analg. 2000;90:933-7.

Farrar JT, Young Jr JP, LaMoreaux L. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94:149-58.

Dunn KM, Saunders KW, Rutter CM. Opioid prescriptions for chronic pain and overdose a cohort study. Ann Intern Med. 2010;152:85-92.

Pharmacological management of persistent pain in older per- sons. J Am Geriatr Soc. 2009;57:1331-46.

Ray WA, Varas-Lorenzo C, Chung CP. Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospi- talization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes. 2009;2:155-63.

Gloth FM. Pharmacological management of persistent pain in older persons focus on opioids and nonopioids. J Pain. 2011;12:S14-20.

Buckeridge D, Huang A, Hanley J. Risk of injury asso- ciated with opioid use in older adults. J Am Geriatr Soc. 2010;58:1664-70.

Saunders KW, Dunn KM, Merrill JO. Relationship of opioid use and dosage levels to fractures in older chronic pain patients. J Gen Intern Med. 2010;25:310-5.

Mattia C, Di Bussolo E, Coluzzi F. Non-analgesic effects of opi- oids the interaction of opioids with bone and joints. Curr Pharm Des. 2012;18:6005-9.

Pergolizzi J, Boger RH, Budd K. Opioids and the manage- ment of chronic severe pain in the elderly consensus statement of an International Expert Panel with focus on the six clini- cally most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, mor- phine, oxycodone). Pain Pract. 2008;8:287-313.

King S, Forbes K, Hanks GW. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment a European Palliative Care Research Collaborative opioid guidelines project. Palliat Med. 2011;25:525-52.

Hanna M. The effects of liver impairment on opioids used to relieve pain in cancer patients. Palliat Med. 2011;25:604-5.

Muijsers RB, Wagstaff AJ. Transdermal fentanyl an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs. 2001;61:2289-307.

Skorpen F, Laugsand EA, Klepstad P. Variable response to opioid treatment any genetic predictors within sight?. Palliat Med. 2008;22:310-27.

Droney J, Riley J. Recent advances in the use of opioids for cancer pain. J Pain Res. 2009;2:135-55.

Overholser BR, Foster DR. Opioid pharmacokinetic drug-drug interactions.. Am J Manage Care.. 2011;17:S276-87.

Afilalo M, Stegmann JU, Upmalis D. Tapentadol immediate release a new treatment option for acute pain management. J Pain Res. 2010;3:1-9.

Fillingim RB, King CD, Ribeiro-Dasilva MC. Sex, gender, and pain a review of recent clinical and experimental findings. J Pain. 2009;10:447-85.

Greenspan JD, Craft RM, LeResche L. Studying sex and gender differences in pain and analgesia: a consensus report.. Pain. 2007:S26-45.

Hurley RW, Adams MC. Sex, gender, and pain an overview of a complex field. Anesth Analg. 2008;107:309-17.

Hale M, Upmalis D, Okamoto A. Tolerability of tapen- tadol immediate release in patients with lower back pain or osteoarthritis of the hip or knee over 90 days a randomized, double-blind study. Curr Med Res Opin. 2009;25:1095-104.

Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoact Drugs. 2003;35:253-9.

Handelsman L, Cochrane KJ, Aronson MJ. Two new rat- ing scales for opiate withdrawal. Am J Drug Alcohol Abuse. 1987;13:293-308.

Chou R, Fanciullo GJ, Fine PG. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113-30.

Butler SF, Budman SH, Fernandez K. Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004;112:65-75.

Butler SF, Fernandez K, Benoit C. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R). J Pain. 2008;9:360-72.

Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients preliminary validation of the Opioid Risk Tool. Pain Med. 2005;6:432-42.

Belgrade MJ, Schamber CD, Lindgren BR. The DIRE score pre- dicting outcomes of opioid prescribing for chronic pain. J Pain. 2006;7:671-81.

Couwenbergh C, Van Der Gaag RJ, Koeter M. Screening for substance abuse among adolescents validity of the CAGE- AID in youth mental health care. Subst Use Misuse. 2009;44:823-34.

Brown RL, Rounds LA. Conjoint screening questionnaires for alcohol and other drug abuse criterion validity in a primary care practice. Wis Med J. 1995;94:135-40.

Good clinical practice guide for opioids in pain management: the three Ts - titration (trial), tweaking (tailoring), transition (tapering)

Orientação para boa prática clínica para opioides no tratamento da dor: os três "Ts" - titulação (teste), ajustes (individualização), transição (redução gradual)

Flaminia Coluzzi; Robert Taylor Jr.; Joseph V. Pergolizzi Jr.; Consalvo Mattia; Robert B. Raffa

Abstract

Keywords

Resumo

Palavras-chave

References

Links

Share

Braz J Anesthesiol